Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyoscine + dexamethasone versus dexamethasone + ondansetron for prevention of post-cesarean nausea and vomiting
IRCT20250412065291N5Phase 3Recruiting
- Sponsor
- Ilam University of Medical Sciences
- Start
- Oct 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of scopolamine, dexamethasone and ondansetron in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Ilam University of Medical Sciences. Primary endpoints: Severity of nausea, Patient satisfaction and 1 more. Started Oct 2026; status: recruiting.
02
Drugs
scopolaminedexamethasoneondansetron
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20250412065291N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250412065291N5.